Dermatology Physicians, Inchttps://Web.Qiesnet.Org

CLIA Laboratory Citation Details

2
Total Citations
13
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 39D2110303
Address 1613 Oregon Pike, Lancaster, PA, 17601
City Lancaster
State PA
Zip Code17601
Phone(717) 807-7294

Citation History (2 surveys)

Survey - September 9, 2020

Survey Type: Standard

Survey Event ID: 1BRW11

Deficiency Tags: D5217 D6053 D5217 D5449 D5209 D5449 D6053

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on review of the laboratory's competency assessment policy, competency assessment records and interview with the nursing supervisor (NS), the laboratory failed to follow their competency assessment procedure to assess the competency of 1 of 2 clinical consultants in 2019. Findings Include: 1. The competency assessment policy states, "Staff who hold CLIA supervisor postions: General supervisor, technical consultant, technical supervisor, or clinical consultant will be assessed annually for their supervisory competence in addition to laboratory testing competence, if performing testing samples." 2. On the day of survey, 09/09/2020, the laboratory could not provide competency assessment records for 1 of 2 clinical consultants, for their supervisory responsibilities in 2019. 3. The NS confirmed the findings above on 09/09/2020 around 12:45 pm. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on review of KOH/ wet mount peer review records and interview with the nursing supervisor (NS), the laboratory failed to ensure 4 of 5 testing personnel (TP) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- performed in the verification of accuracy for KOH/ wet mount examinations analyzed in 2018, 2019 and 2020. Findings Include: 1. On the day of survey, 09/09/2020, the NS could not provide peer review records performed onsite for 4 of 5 TP analyzing KOH/ wet mount examination in 2018, 2019 and 2020. 2. The NS confirmed the finding above on 09/09/2020 around 1:05 pm. ***KOH = Potassium Hydroxide D5449 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(ii)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Each qualitative procedure, include a negative and positive control material; (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on review of KOH/ wet mount examination quality control (QC) records and interview with the nursing supervisor (NS), the laboratory failed to document QC procedures each day of patient testing for 40 of 50 KOH/ wet mount examinations analyzed from 2019 to 2020. Findings Include: 1. On the day of survey, 09/09/2020, review of KOH/wet mount examination QC records revealed, the laboratory did not document QC procedures for KOH/ wet mount examinations each day of patient testing for 32 of 36 patient specimen analyzed in 2019 and 8 of 14 patient specimen analyzed in 2020. 2. In 2019, 36 KOH/ wet mount examinations were analyzed. 3. In 2020, 14 KOH/ wet mount examinations were analyzed. 4. The NS confirmed the findings above on 09/09/2020 around 1:00 pm. *** = Potassium Hydroxide ****Repeat Deficiency*** D6053 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(9) The technical consultant is responsible for evaluating and documenting the performance of individuals responsible for moderate complexity testing at least semiannually during the first year the individual tests patient specimens. This STANDARD is not met as evidenced by: Based on review of testing personnel (TP) competency assessment records and interview with the nursing supervisor (NS), the technical consultant (laboratory director) failed to evaluate and document the performance of 1 of 4 TP analyzing KOH and wet mount examinations at least semiannually during the first year in 2020. Findings Include: 1. On the day of survey, 09/09/2020, review of TP #4 (1 of 4 TP) competency assessment records revealed, TP#4 was not assessed at least semiannually during the first year of testing patient specimens for KOH and wet mount examinations. 2. TP# 4 was initially assessed for competency on 08/12/2019 and not again until 08/04/2020. 3. The NS confirmed the findings above on 09/09/2020 around 12:40 pm. ***KOH = Potassium Hydroxide -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - March 13, 2018

Survey Type: Standard

Survey Event ID: Z08811

Deficiency Tags: D5407 D5449 D5449 D5417 D6051 D6051

Summary:

Summary Statement of Deficiencies D5407 PROCEDURE MANUAL CFR(s): 493.1251(d) Procedures and changes in procedures must be approved, signed, and dated by the current laboratory director before use. This STANDARD is not met as evidenced by: Based on observation and review of procedure manuals, and interview with the Mohs Tech and a Registered Nurse (RN), the laboratory Director failed ensure that an approved procedure manual is available to all personnel responsible for any aspect of the testing process. Findings include: 1. On the date of survey, 03/13/2018, the Procedure manual reviewed at the time of inspection , revealed that the laboratory director has been delegating of procedure manuals for revisions and updates to one of the RN's. 2. The Procedure manual did not have the current laboratories director's signature and date of approval. 3. Appendix C states "Approval of procedures and changes to procedures is the responsibility of the laboratory director. This responsibility cannot be delegated." 4. The Mohs Tech and a Registered Nurse (RN), confirmed the finding above on 03/13/2018 around 03:00 PM. D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on tour of Histology Laboratory and interview with the Mohs Tech and a Registered Nurse (RN), the laboratory failed to ensure that Tissue Marking Dye is not Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- used beyond its expiration date. Finding Include: 1. On the Date of survey, 03/13 /2018, during the tour of the Histology laboratory, 1 of 1 bottle of Yellow Avantik Tissue Marking Dye was discovered that expired 01/2018. 2. From the expiration date of the yellow tissue marking dye (01/2018) to the date of survey (03/13/2018), 331 slides were read. 2. The Mohs Tech and a Registered Nurse (RN) confirmed the findings above on 03/13/2018 around 02:45 PM. D5449 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(ii)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Each qualitative procedure, include a negative and positive control material; (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on, the review of laboratory's quality control records, and interview with the Mohs Tech and a Registered Nurse (RN), the laboratory failed to perform quality control for potassium hydroxide (KOH) and wet mount microscopic examination from 2017 to the date of survey. Findings: 1. On the date of survey 03/13/2018, review of the laboratory's quality control records revealed that the the Laboratory Quality control form for KOH and Wet mounts review if the slide is intact and if the reagents are current but does not include the qualitative procedure, include a negative and positive control material (can be reference material). 2. Roughly 50 specimen were examined for KOH and Wet mount each year in 2016 and 2017. 3. The Mohs Tech and RN confirmed the findings above on 03/13/2018 around 03:30 PM. D6051 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(8)(v) The procedures for evaluation of the competency of the staff must include, but are not limited to assessment of test performance through testing previously analyzed specimens, internal blind testing samples or external proficiency testing samples. This STANDARD is not met as evidenced by: Based on, the review of competency assessment records, peer review records and interview with the Mohs tech and a Registered nurse (RN) the Technical Consultant (TC) (Laboratory Director) failed to assess the competency of all Testing personnel through internal blind testing samples or external Peer review samples in 2017. Findings Include: 1. On the date of survey, 03/13/2018, review of competency assessment records and 2017 Histology peer review records revealed the TC did not assess test performance of 1 of 3 (TP#3) through internal blind testing samples, external PT, or peer review samples in 2017. 2. In 2017, 1273 specimen were read. 2. the Mohs tech and a RN confirmed the findings above on 03/13/2018 around 02:30 PM. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access